TrialDiabetes, obesity & metabolism2016

Efficacy and safety of ipragliflozin as add-on therapy to insulin in Japanese patients with type 2 diabetes mellitus (IOLITE): a multi-centre, randomized, placebo-controlled, double-blind study.

Hisamitsu Ishihara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.